Neko Health raises $700m Series C as preventative care model reaches profitability
The Stockholm-based healthtech startup has reached 100k members and achieved clinic-level profitability, signaling strong investor confidence in Europe’s preventative care market.
Stockholm-based healthtech company Neko Health has raised $700 million in a Series C funding round, marking a major milestone for the preventative care sector. The company announced that it has now surpassed 100k members and achieved profitability at the clinic level.
The funding news comes as CEO Hjalmar Nilsonne oversees operations from the company’s refurbished first clinic in Stockholm. The decision to conduct business directly within the clinical space underscores the company’s integrated, hands-on approach to healthcare delivery and operational oversight.
For European markets, this development is a significant signal. Healthtech startups have historically struggled to prove sustainable unit economics, often burning through venture capital to subsidize patient acquisition and hardware costs. Neko Health’s ability to reach clinic-level profitability demonstrates that a premium, preventative scanning model can viably scale.
The $700 million injection will likely accelerate the company’s physical expansion across Europe and potentially into new international markets. In the current investment climate, backers are increasingly prioritizing capital efficiency and clear paths to profitability over pure user growth metrics. By proving that its physical clinics can operate profitably, Neko Health positions itself favorably for late-stage investment in a cautious macroeconomic environment.
The milestone of 100k members also reflects a broader consumer shift toward proactive health management. Patients are increasingly willing to invest in early detection and comprehensive health data, moving away from purely reactive, traditional healthcare systems.
As Neko Health scales its clinic model, it sets a new benchmark for European digital health companies. The combination of substantial late-stage funding and verified clinic-level profitability suggests that the preventative health sector is maturing. It is transitioning from a speculative niche into a sustainable, mainstream component of the broader healthcare economy, offering a blueprint for other startups aiming to bridge the gap between technology and clinical care.
+109
